Table 2.
Overview of functional outcomes of the included studies
| Urinary function | IPSS | ||||||
|---|---|---|---|---|---|---|---|
| Study | Technique | Post-op (timepoint not specified) | 1 m | 3 m | 6 m | 12 m | 24 m |
| Annibale et al. | L-TME/R-TME | NS | NS | ||||
| Feng et al. | L-TME/R-TME | RS | RS | RS | |||
| Galata et al. | L-TME/R-TME | ∆ NS | |||||
| Grass et al. | R-TME/TaTME | ∆ ♂ TaS, ∆ ♀ NS | |||||
| Jayne et al.* | L-TME/R-TME | NS* | |||||
| Kim et al. (ASO) | L-TME/R-TME | NS | RS | NS | NS | ||
| Kim et al. (CRD) | L-TME/R-TME | NS | RS | NS | |||
| Liu et al. | L-TME/Microhand/da Vinci | RS3, RS4 | |||||
| Macháčková et al. | L-TME/R-TME | NS | NS | NS | |||
| Miura et al. | L-TME/R-TME/TaTME | NS1, NS2 | |||||
| Park et al. | L-TME/R-TME | NS | NS | NS | |||
| Tang et al. | L-TME/R-TME | NS | RS | RS | |||
| Sexual function | IIEF | FSFI | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Study | Technique | 1 m | 3 m | 6 m | 12 m | 24 m | 3 m | 6 m | 12 m | 24 m |
| Feng et al. | L-TME/R-TME | RS | RS | RS | RS | RS | RS | |||
| Galata et al. | L-TME/R-TME | NS | ∆ NS | |||||||
| Grass et al. | R-TME/TaTME | ∆ NS | ||||||||
| Jayne et al.* | L-TME/R-TME | NS* | NS* | |||||||
| Kim et al. (ASO) | L-TME/R-TME | NS | NS | NS | NS | |||||
| Kim et al. (CRD) | L-TME/R-TME | NS | NS | NS | ||||||
| Liu et al. | L-TME/Microhand/da Vinci | RS1, RS2 | NS1, NS2 | |||||||
| Macháčková et al. | L-TME/R-TME | NS | NS | NS | NS | NS | NS | |||
| Park et al. | L-TME/R-TME | NS | RS | NS | ||||||
| Tang et al. | L-TME/R-TME | NS | RS | NS | ||||||
| Fecal function | LARS | Wexner | |||
|---|---|---|---|---|---|
| Study | Technique | 6 m postoperatively or after stoma closure | 12 m | 6 m postoperatively or after stoma closure | 12 m |
| Grass et al. | R-TME/TaTME | ∆ RS | ∆ NS | ||
| Heijden et al. | L-TME/TaTME | LS | |||
| Miura et al. | L-TME/R-TME/TaTME | NS1, NS2 | NS1, NS2 | ||
| Rubinkiewicz et al.* | L-TME/TaTME | NS* | NS* | ||
IPSS International Prostate Symptom Score; L-TME laparoscopic total mesorectal excision; m months; NS non-significant; Post-op postoperative; R-TME robotic total mesorectal excision; RS robot significantly better; TaTME transanal total mesorectal excision; TaS transanal significantly better; FSFI female sexual function index; IIEF International Index of Erectile Function; LS laparoscopic significantly better; LARS low anterior resection syndrome
*Calculated L-TME minus R-TME; ♂, male; ♀, female; 1L-TME vs. R-TME; 2R-TME vs. TaTME; 3Microhand vs. L-TME; 4da Vinci vs. L-TME; ∆, delta. The reported significance of the questionnaire outcomes was reported as described by the reviewed studies and according to comparison to preoperative baseline questionnaire outcomes, unless otherwise specified
*Calculated L-TME minus R-TME; 1Microhand vs. L-TME; 2da Vinci vs. L-TME; ∆, delta
*Provided median LARS/Wexner scores; ∆, delta; 1L-TME vs. R-TME; 2R-TME vs. TaTME